Statin Therapy

Experts agree that whether statin-associated adverse effects are real or not matters little if a patient cannot or will not take the statin because of the symptoms they describe.

Decades of data demonstrate the benefits of statin therapy for people at high CV risk, yet many patients — particularly women — are not treated with statins.

Editor's Note: This is part 1 of a three-part Healio Exclusive series on navigating statin intolerance.

After years of failed attempts to develop therapies meant to reduce elevated triglycerides, novel agents are now showing promise in the management of hypertriglyceridemia, a speaker said.

BOSTON — In this Healio video exclusive, Paul M. Ridker, MD, MPH, discusses the use of low-dose colchicine to target inflammation in patients who remain at high CVD risk despite controlled LDL.

BOSTON — After years of failed clinical trials with agents to lower severely elevated triglycerides, emerging therapeutics hold promise for effectively addressing hypertriglyceridemia and reducing associated CV risks, a speaker reported.

The 2023 Cardiometabolic Health Congress will return in-person to Boston with the latest updates spanning all aspects of cardiometabolic health, including CVD, diabetes, kidney disease, lipid and lifestyle management and obesity.

Online patient education materials about statins often exceed the reading level of many patients, and reliability varies widely across sources, complicating efforts to improve medication initiation and adherence, researchers reported.

Healio and Cardiology Today have compiled a list of the top news in cardiology of September 2023.

Older individuals appeared to derive similar magnitude of LDL lowering and CV risk reduction from statin therapy initiation vs. younger patients, according to data from a large Danish study.